Scintigraphic load of bone disease evaluated by DASciS software as a survival predictor in metastatic castration-resistant prostate cancer patients candidates to 223RaCl treatment
, , , , , , , y
19 dic 2019
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 19 dic 2019
Páginas: 40 - 47
Recibido: 18 jun 2019
Aceptado: 22 oct 2019
DOI: https://doi.org/10.2478/raon-2019-0058
Palabras clave
© 2020 Viviana Frantellizzi, Arianna Pani, Maria Dea Ippoliti, Alessio Farcomeni, Irvin Aloise, Mirco Colosi, Claudia Polito, Roberto Pani, Giuseppe De Vincentis, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Frantellizzi, Viviana
Department of Molecular Medicine, Sapienza University of RomeRome, Italy
Pani, Arianna
Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan “Statale”Milan, Italy
Ippoliti, Maria Dea
Department of Radiological Sciences, Oncology and Anatomical Pathology , Sapienza University of RomeRome, Italy
Farcomeni, Alessio
Department of Public Health and Infectious Diseases, “Sapienza” University of RomeRome, Italy
Aloise, Irvin
Department of Computer, Control, and Management Engineering Antonio Ruberti, Sapienza University of RomeRome, Italy
Colosi, Mirco
Department of Computer, Control, and Management Engineering Antonio Ruberti, Sapienza University of RomeRome, Italy
Polito, Claudia
Specialty School in Medical Physics, Department of Medico-Surgical Sciences and Biotechnologies, University La SapienzaRome, Italy
Pani, Roberto
Specialty School in Medical Physics, Department of Medico-Surgical Sciences and Biotechnologies, University La SapienzaRome, Italy
Vincentis, Giuseppe De
Department of Radiological Sciences, Oncology and Anatomical Pathology , Sapienza University of RomeRome, Italy